(18)F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma.
- DOI
- 10.1186/s12880-026-02669-6
- Published
- 2026 Aug 11
- Container
- BMC medical imaging
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12880-026-02669-6,
title = {(18)F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma.},
author = {Liu J and Ren Q and Li S and Zheng L and Yang X and Zhu X and Zhang M and Sun J and Liu J and Wang H and Yang J and Wang W},
year = {2026},
journal = {BMC medical imaging},
doi = {10.1186/s12880-026-02669-6},
url = {https://doi.org/10.1186/s12880-026-02669-6}
}RIS
TY - JOUR TI - (18)F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma. AU - Liu J AU - Ren Q AU - Li S AU - Zheng L AU - Yang X AU - Zhu X AU - Zhang M AU - Sun J AU - Liu J AU - Wang H AU - Yang J AU - Wang W PY - 2026 JO - BMC medical imaging DO - 10.1186/s12880-026-02669-6 UR - https://doi.org/10.1186/s12880-026-02669-6 ER -
APA
J, L., Q, R., S, L., L, Z., X, Y., X, Z., M, Z., J, S., J, L., H, W., J, Y., & W, W. (2026). (18)F-FDG PET/CT-based Metabolic-clinical prognostic model could refine risk stratification in high-risk neuroblastoma.. BMC medical imaging. https://doi.org/10.1186/s12880-026-02669-6
Source records
- pubmed · retrieved 2026-11-10T18:53:08.947Z